NCT02482324View on ClinicalTrials.gov

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

ALZT-OP1a

Mast cell stabilizer

DRUG

ALZT-OP1b

anti-inflammatory

DEVICE

Dry Powder Inhaler

The inhaler will be used to deliver ALZT-OP1a via oral inhalation for both days on study.

Trial Locations (1)

33014

Panax Clinical Research, Miami Lakes

Sponsors

Lead Sponsor

AZTherapies, Inc.
All Listed Sponsors
collaborator

Panax Clinical Research

OTHER

collaborator

Pharma Consulting Group AB

INDUSTRY

collaborator

KCAS

UNKNOWN

lead

AZTherapies, Inc.

INDUSTRY